[go: up one dir, main page]

CN1888051B - Plant lactobacillus strain and its application - Google Patents

Plant lactobacillus strain and its application Download PDF

Info

Publication number
CN1888051B
CN1888051B CN200510080072A CN200510080072A CN1888051B CN 1888051 B CN1888051 B CN 1888051B CN 200510080072 A CN200510080072 A CN 200510080072A CN 200510080072 A CN200510080072 A CN 200510080072A CN 1888051 B CN1888051 B CN 1888051B
Authority
CN
China
Prior art keywords
lactobacillus
vaginal
lactobacillus plantarum
women
cgmcc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200510080072A
Other languages
Chinese (zh)
Other versions
CN1888051A (en
Inventor
陈薇
张俊
端青
曹琇蓉
陈浪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Tianyouda Bioengineering Sci Tech Co ltd
Institute of Microbiology and Epidemiology of AMMS
Original Assignee
Beijing Tianyouda Bioengineering Sci Tech Co ltd
Institute of Microbiology and Epidemiology of AMMS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Tianyouda Bioengineering Sci Tech Co ltd, Institute of Microbiology and Epidemiology of AMMS filed Critical Beijing Tianyouda Bioengineering Sci Tech Co ltd
Priority to CN200510080072A priority Critical patent/CN1888051B/en
Publication of CN1888051A publication Critical patent/CN1888051A/en
Application granted granted Critical
Publication of CN1888051B publication Critical patent/CN1888051B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了一株植物乳杆菌及其应用。本发明所公开的植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329分离自中国孕妇阴道分泌物,对妇女阴道常见的致病菌如金黄色葡萄球菌、白色念珠菌、大肠杆菌和阴道加德纳菌有较强的抑菌作用,产酸和产H202的能力均高于其它乳酸杆菌,培养96小时,培养液的pH可达3.96;该菌株表面具有厚厚的非菌毛黏附素,对阴道上皮细胞有较好的黏附作用,并且在室温适宜的保存液中放置,活菌数增加3×104倍。植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329可用于制备阴道微生态制剂,用以预防和/或治疗妇女阴道感染性疾病。The invention discloses a plant lactobacillus and application thereof. Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329 disclosed in the present invention is isolated from the vaginal secretions of pregnant women in China, and is effective against common pathogenic bacteria in women's vaginas such as Staphylococcus aureus, Candida albicans, Escherichia coli and vaginal Gardner The bacterium has strong antibacterial effect, and the ability to produce acid and H 2 0 2 is higher than that of other lactobacilli. After 96 hours of culture, the pH of the culture solution can reach 3.96; the surface of the strain has thick non-pilus adhesin , has good adhesion to vaginal epithelial cells, and placed in a preservation solution at a suitable room temperature, the number of viable bacteria increases by 3×10 4 times. Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329 can be used to prepare vaginal microecological preparations for preventing and/or treating women's vaginal infectious diseases.

Description

一株植物乳杆菌及其应用 A strain of Lactobacillus plantarum and its application

技术领域technical field

本发明涉及一株乳酸杆菌及其应用,特别涉及一株植物乳杆菌及其应用。The invention relates to a strain of Lactobacillus and its application, in particular to a strain of Lactobacillus plantarum and its application.

背景技术Background technique

一、乳酸杆菌和妇女阴道病1. Lactobacillus and women's vaginosis

乳酸杆菌(Lactobacillus)是健康妇女阴道内主要的、也是最重要的正常菌群,阴道内乳酸杆菌不但无致病性,而且能自洁阴道微生态环境,制约其它致病菌定植生长。因此,临床上将阴道涂片可见大量(高倍镜下每个视野数个)乳酸杆菌,未察见或仅有少量革兰氏阴性杆菌作为正常、无阴道感染的标准,而阴道内乳酸杆菌缺失或减少是阴道感染的重要指标(Robert P.Nugent,Marijane A.Krohn,and Sharon L.Hillier Reliability of diagnosing bacterial vaginosisis improved by a standardized method of Gram stain interpretation Journalof Clincal Microbiology 1991,29(2):297-301)。Lactobacillus (Lactobacillus) is the main and most important normal flora in the vagina of healthy women. Lactobacillus in the vagina is not only non-pathogenic, but also can self-clean the micro-ecological environment of the vagina and restrict the colonization and growth of other pathogenic bacteria. Therefore, clinically, a large number of lactobacilli (several per field of view under a high-power microscope) can be seen in vaginal smears, and no or only a small amount of Gram-negative bacilli can be seen as the standard of normal and no vaginal infection, while lactobacilli in the vagina are absent Or reduction is an important indicator of vaginal infection (Robert P.Nugent, Marijane A.Krohn, and Sharon L.Hillier Reliability of diagnosing bacterial vaginosis improved by a standardized method of Gram stain interpretation Journal of Clincal Microbiology 1991,297-2): 301).

妇女细菌性阴道病(Bacterial Vaginosis,简称BV)主要是指由细菌、霉菌、滴虫等微生物引起的阴道炎,临床一般使用抗生素治疗,但抗生素治疗有较高的复发率,尤其对于一些老年性阴道炎和多发性阴道炎患者,抗生素治疗往往效果不佳,因为在使用抗生素杀灭致病微生物的同时也破坏了体内的正常菌群,尤其是抑制了阴道内乳酸杆菌的生长,从而失去了对微生态环境中致病微生物的制约作用,使其它致病微生物定植生长。另外,妇女怀孕期间由于免疫调节紊乱易发阴道感染,而孕妇的特殊性使其不能使用抗生素治疗。Women's bacterial vaginosis (Bacterial Vaginosis, referred to as BV) mainly refers to vaginitis caused by bacteria, molds, trichomonas and other microorganisms. Clinically, antibiotics are generally used for treatment, but antibiotic treatment has a high recurrence rate, especially for some elderly patients. For patients with vaginitis and multiple vaginitis, antibiotic treatment is often ineffective, because the use of antibiotics to kill pathogenic microorganisms also destroys the normal flora in the body, especially inhibits the growth of Lactobacillus in the vagina, thus losing The restrictive effect on pathogenic microorganisms in the micro-ecological environment allows other pathogenic microorganisms to colonize and grow. In addition, women are prone to vaginal infections due to immune regulation disorders during pregnancy, and the particularity of pregnant women prevents them from being treated with antibiotics.

二、乳酸杆菌阴道制剂的应用情况2. The application of Lactobacillus vaginal preparations

乳酸杆菌作为微生态制剂治疗妇女阴道病在国外已得到广泛应用(Nigel W.Mclean and Isobel J.Rosenstein Characterisation and selection of aLactobacillus species to re-colonise the vagina of women with recurrentbacterial vaginosis L Med Microbiol 2000,49:543-552;Elmer GM.Probiotics:”living drugs”Am J Health Syst Pharm 2001,58(12):1101-9),该药属非处方制剂,患者可自行购买。制剂中的乳酸杆菌一般自正常妇女阴道中分离,常见的有嗜酸乳杆菌(Lactobacillus acidophilus)、干酪乳杆菌(Lactobacillus casei)和植物乳杆菌(Lactobacillus plantarum)等。由于人种和个体的差异,国外同类制剂不一定适宜包括中国人在内的亚洲人,国内已开始研制同类制剂乳杆菌。Lactobacillus has been widely used abroad as a microecological agent to treat vaginosis in women (Nigel W. Mclean and Isobel J. Rosenstein Characterization and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis L Med Microbiol 2000, 49: 543-552; Elmer GM. Probiotics: "living drugs" Am J Health Syst Pharm 2001, 58(12): 1101-9), which is an over-the-counter preparation that patients can purchase by themselves. The Lactobacillus in the preparation is generally isolated from the vagina of normal women, and the common ones are Lactobacillus acidophilus, Lactobacillus casei and Lactobacillus plantarum. Due to race and individual differences, similar foreign preparations may not be suitable for Asians including Chinese, and similar preparations of Lactobacillus have been developed in China.

应用微生态制剂治疗疾病,肯定是抗生素辉煌时代后的又一灿烂亮点,是抗生素无法取代的又一制药方向,蕴藏着巨大的经济效益和社会效益。The application of probiotics to treat diseases is definitely another bright spot after the glorious era of antibiotics, and it is another pharmaceutical direction that antibiotics cannot replace, with huge economic and social benefits.

乳酸杆菌作为阴道内微生态制剂适合于以下人群:Lactobacillus as an intravaginal microecological preparation is suitable for the following groups of people:

(1)老年阴道炎患者(1) Elderly patients with vaginitis

老年阴道炎既萎缩性阴道炎,是老年妇女常见病之一,在绝经妇女中阴道炎发病率国内报道为30-50%,国外报道为30%.专家认为老年阴道炎的主要病因是阴道微环境中乳酸杆菌缺乏,其它致病微生物定植所致.抗生素治疗老年阴道炎效果不佳,而定期植入乳酸杆菌制剂可抑制其它致病菌生长,是改善老年患者阴道炎症状,使其处于健康状态,从而提高老年妇女生活质量的根本途径(Reid G,Bruce AW.Urogenital infections in women:can probiotics help?PostgradMed J.2003 Aug;79(934):428-32)。Senile vaginitis is atrophic vaginitis, which is one of the common diseases of elderly women. The incidence rate of vaginitis in postmenopausal women is 30-50% in domestic reports and 30% in foreign countries. Experts believe that the main cause of senile vaginitis is vaginal microscopic The lack of Lactobacillus in the environment is caused by the colonization of other pathogenic microorganisms. Antibiotics are not effective in treating senile vaginitis, and regular implantation of Lactobacillus preparations can inhibit the growth of other pathogenic bacteria, which is to improve the symptoms of vaginitis in elderly patients and keep them in a healthy state. status, thereby improving the quality of life of elderly women (Reid G, Bruce AW. Urogenital infections in women: can probiotics help? PostgradMed J. 2003 Aug; 79 (934): 428-32).

(2)孕妇(2) Pregnant women

孕妇与正常妇女比较,由于激素水平的变化引起T抑制淋巴细胞亢进,从而造成免疫力低下,易发生生殖泌尿系感染。治疗孕妇感染一般不使用抗生素,因为大多数抗生素对胎儿有影响,例如用于治疗滴虫和厌氧菌性阴道炎的药物“灭滴灵”,动物实验中显示有致癌和致畸作用,用于治疗非特异性阴道炎的大环内酯类药物影响胎儿骨骼发育。而乳酸杆菌是正常菌群,无致病性,对阴道微环境有自洁作用。因此对于患有阴道炎的孕妇阴道内植入乳酸杆菌制剂,可使其安全渡过孕期以及围产期。孕妇感染BV容易引起子宫内膜炎和早产,英国最新的调查表明,妊娠20周时,阴道内克隆有产H2O2的乳酸杆菌的孕妇,其患BV的危险性大大低于无产H2O2的乳酸杆菌的孕妇,其子宫内膜炎的患病率和早产率也大大低于后者(Wilks M,Wiggins R,Whiley A,Hennessy E,Warwick S,Porter H,CorfieldA,Millar M.Identification and H(2)O(2)production of vaginal lactobacillifrom pregnant women at high risk of preterm birth and relation with outcome.J Clin Microbiol.2004 Feb;42(2):713-7)。因此,有人利用产H2O2的乳酸杆菌菌液为22名患有BV,年龄在20-34岁、妊娠3个月的孕妇冲洗阴道,每天冲洗1次,冲洗7天为1个疗程,隔1周后开始第2疗程。结果治疗3天后全部孕妇症状得到改善,2个疗程后90%孕妇阴道状况恢复正常(Tasdemir M,Tasdemir I,Tasdemir S,Tavukcuoglu S.Alternative treatment for bacterial vaginosisin pregnant patients;restoration of vaginal acidity and flora.Arch AIDSRes.1996;10(4):239-41)。Compared with normal women, pregnant women are prone to genitourinary infection due to decreased immunity due to the increase in T-suppressed lymphocytes caused by changes in hormone levels. Antibiotics are generally not used to treat infections in pregnant women, because most antibiotics have an impact on the fetus. For example, the drug "Metronidyl" used to treat trichomonas and anaerobic vaginitis has been shown to have carcinogenic and teratogenic effects in animal experiments. Macrolide drugs used in the treatment of non-specific vaginitis affect fetal bone development. Lactobacillus is a normal flora, non-pathogenic, and has a self-cleaning effect on the vaginal microenvironment. Therefore, implanting lactobacillus preparations into the vagina of pregnant women suffering from vaginitis can safely pass through the pregnancy and perinatal period. Pregnant women infected with BV are likely to cause endometritis and premature delivery. The latest survey in the UK shows that at 20 weeks of pregnancy, pregnant women who have Lactobacillus producing H 2 O 2 in their vagina have a much lower risk of developing BV than those without H 2 Pregnant women with Lactobacillus O2 had significantly lower endometritis prevalence and premature delivery than the latter (Wilks M, Wiggins R, Whiley A, Hennessy E, Warwick S, Porter H, Corfield A, Millar M. Identification and H(2)O(2)production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome. J Clin Microbiol. 2004 Feb; 42(2):713-7). Therefore, someone used H 2 O 2 producing Lactobacillus bacteria liquid to wash the vagina of 22 pregnant women with BV, aged 20-34, who were 3 months pregnant, once a day, and 7 days was a course of treatment. Start the second course of treatment 1 week later. Results After 3 days of treatment, the symptoms of all pregnant women were improved, and 90% of the pregnant women's vaginal conditions returned to normal after 2 courses of treatment (Tasdemir M, Tasdemir I, Tasdemir S, Tavukcuoglu S. Alternative treatment for bacterial vaginosis in pregnant patients; restoration of vaginal acidity and flora.Arch AIDS Res. 1996;10(4):239-41).

(3)慢性病患者(3) Patients with chronic diseases

对于慢性病患者,如糖尿病患者,红斑狼疮、风湿病、器官移植等长期使用免疫抑制剂和广普抗生素的人群,常常会出现正常菌群失调;一些肢体残疾、长期坐卧的女性阴道容易感染厌氧菌;对于这类妇女,植入乳酸杆菌阴道制剂,将会为她们解除痛苦,起到有效的“保洁”作用。For patients with chronic diseases, such as diabetes patients, lupus erythematosus, rheumatism, organ transplantation and other long-term use of immunosuppressants and broad-spectrum antibiotics, normal flora imbalance often occurs; some physically disabled, long-term sitting and lying women are prone to vaginal infections. Oxygen bacteria; For such women, implanting lactobacillus vaginal preparations will relieve their pain and play an effective "cleaning" role.

三、用作乳酸杆菌阴道制剂菌株的来源和应具有的条件3. The source and conditions for the strains used as Lactobacillus vaginal preparations

1、用作乳酸杆菌阴道制剂菌株的来源1. Used as a source of Lactobacillus vaginal preparation strains

用作乳酸杆菌阴道微生态制剂的菌株一般均来源于健康妇女阴道正常菌群,而分离自阴道清洁度极好的孕妇阴道正常菌群的乳酸杆菌将会有更好的效果。1999年英国报道从孕妇分离乳酸杆菌用于研制阴道微生态制剂。The strains used as Lactobacillus vaginal microecological preparations are generally derived from the normal vaginal flora of healthy women, and Lactobacillus isolated from the normal vaginal flora of pregnant women with excellent vaginal cleanliness will have a better effect. In 1999, it was reported in the UK that Lactobacillus isolated from pregnant women was used to develop vaginal microecological preparations.

孕妇在孕期,尤其是在孕前期,由于激素水平的变化引起机体免疫系统絮乱,常常是T抑制细胞亢进造成免疫力低下,因而易发生生殖泌尿系感染。但在免疫力低下的状态下,有些孕妇仍能保持较好的阴道清洁度,说明其阴道正常菌群,既乳酸杆菌,具有较强抑制致病菌生长的能力。Pregnant women during pregnancy, especially in the early pregnancy, due to changes in hormone levels, the body's immune system is disordered, often due to the hyperactivity of T suppressor cells, resulting in low immunity, and thus prone to genitourinary infection. However, in the state of low immunity, some pregnant women can still maintain good vaginal cleanliness, indicating that the normal vaginal flora, namely Lactobacillus, has a strong ability to inhibit the growth of pathogenic bacteria.

2、用作乳酸杆菌阴道微生态制剂的菌株一般应具有以下几个方面的条件:2. The strains used as Lactobacillus vaginal microecological preparations should generally have the following conditions:

(1)黏附占位性(1) Adhesive space-occupying

乳酸杆菌对阴道上皮细胞的黏附性对于用作微生态制剂非常重要,体外试验表明,乳酸杆菌在硅胶表面生长,可以干扰尿道致病菌在该硅胶表面的吸附(Velraeds MM Interference in initial adhesion of uropathogenic bacteriaand yeasts to silicone rubber by a Lactobacillus acidophilus J MedMicrobiol 1998,47(12):1081-5)。The adhesion of lactobacilli to vaginal epithelial cells is very important for use as probiotics. In vitro tests have shown that the growth of lactobacilli on the surface of silica gel can interfere with the adsorption of urethral pathogenic bacteria on the surface of silica gel (Velraeds MM Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus J Med Microbiol 1998, 47(12): 1081-5).

乳酸杆菌在生长过程中不断向胞外分泌一种非菌毛黏附素,形态学观察可见细菌外周一层厚厚的、致密的、参差不齐、锯齿状物质,又称为毛发样突出物(fibritlae),其化学成分是脂磷壁酸(lipoteichoic acid,LTA),起与宿主细胞的黏附作用。LTA与宿主细胞的黏附作用的机制被认为,一方面作为配体与宿主细胞受体相结合,另一方面通过LTA游离部分所带电荷与宿主细胞间相互作用(Otero MC,Ocana VS,Elena Nader-Macias M.Bacterial surfacecharacteristics applied to selection of probiotic microorganisms.MethodsMol Biol.2004;268:435-40)。因此,革兰氏阳性细菌的毛发样突出物越多,对宿主细胞的黏附作用越强。During the growth process of Lactobacillus, a non-pilus adhesin is continuously secreted to the outside of the cell. Morphological observation shows that there is a thick, dense, uneven, jagged material around the bacteria, also known as fibritlae ), whose chemical composition is lipoteichoic acid (LTA), which plays a role in adhesion to host cells. The mechanism of adhesion between LTA and host cells is considered to be that, on the one hand, it binds to the host cell receptor as a ligand, and on the other hand, it interacts with the host cell through the charge carried by the free part of LTA (Otero MC, Ocana VS, Elena Nader -Macias M. Bacterial surface characteristics applied to selection of probiotic microorganisms. Methods Mol Biol. 2004; 268: 435-40). Thus, the more hair-like protrusions a Gram-positive bacterium has, the stronger its adhesion to the host cell.

乳酸杆菌利用非菌毛黏附素,即毛发样突出物可以很好地附着在阴道壁上,所形成的生物屏障使其它致病菌无法在阴道中形成克隆,起到了占位效应。乳酸杆菌体积越大,占位效应越好。植物乳杆菌(Lactobacillus plantarum),在乳杆菌属中为体积最大的种,因而具有更好的占位性。关于植物乳杆菌用于微生态制剂以及其对阴道上皮细胞具有较好的黏附性和占位性,国外文献和专利已有报道(Bonetti A,Morelli L,Campominosi E,Ganora E,Sforza F.Adherenceof Lactobacillus plantarum P 17630 in soft-gel capsule formulation versusderlein’s bacillus in tablet formulation to vaginal epithelial cells.Minerva Ginecol.2003 Jun;55(3):279-84,284-7)。Lactobacilli use non-pilus adhesin, that is, hair-like protrusions, which can be well attached to the vaginal wall, and the formed biological barrier prevents other pathogenic bacteria from forming clones in the vagina, which plays a role in mass effect. The larger the size of Lactobacillus, the better the mass effect. Lactobacillus plantarum is the largest species in the genus Lactobacillus, so it has better space-occupying properties. Regarding the use of Lactobacillus plantarum in probiotics and its good adhesion and space-occupying properties to vaginal epithelial cells, there have been reports in foreign literature and patents (Bonetti A, Morelli L, Campominosi E, Ganora E, Sforza F.Adherence of Lactobacillus plantarum P 17630 in soft-gel capsule formulation versus susderlein's bacillus in tablet formulation to vaginal epithelial cells. Minerva Ginecol. 2003 Jun; 55(3): 279-84, 284-7).

(2)产酸(2) acid production

由于乳酸杆菌的嗜酸性,使其适于在酸性环境中生长,其发酵糖类所产生的谢产物几乎全部为乙酸,使阴道内环境pH降低,从而不利于其它致病菌生长。年妇女由于其阴道表皮细胞糖元化程度降低,大量乳酸杆菌丢失,因此阴道内微环境pH升高,使得老年妇女容易患阴道炎。因此,许多研究认为,乳酸杆菌的存在所形成的酸性微生态环境,是防止阴道病的最主要因素(E.R.Boskey,K.M.Telsch Acid production gyvaginal flora in vitro is consistent withthe rate and extent of vaginal acidification Infection and Immunity 1999,67(10):5170-5)。Due to the acidophilicity of Lactobacillus, it is suitable for growth in an acidic environment, and the metabolites produced by its fermentation of sugars are almost all acetic acid, which reduces the pH of the vaginal environment, which is not conducive to the growth of other pathogenic bacteria. Due to the reduced degree of glycogenization of vaginal epidermal cells and the loss of a large number of lactobacilli in elderly women, the pH of the vaginal microenvironment increases, making elderly women prone to vaginitis. Therefore, many studies believe that the acidic micro-ecological environment formed by the existence of lactobacillus is the most important factor to prevent vaginosis (E.R.Boskey, K.M.Telsch Acid production gyvaginal flora in vitro is consistent with the rate and extent of vaginal acidification Infection and Immunity 1999, 67(10):5170-5).

(3)产过氧化氢(H2O2)(3) Production of hydrogen peroxide (H 2 O 2 )

有些妇女阴道内寄生的乳酸杆菌数量并不算少,但仍然有炎症发生,这是因为这些乳酸杆菌不产H2O2,而清洁度好的妇女阴道寄生的乳酸杆菌大多产H2O2。如加利亚2003年分别调查了40名健康妇女和72名感染BV妇女阴道菌群的情况,发现健康妇女92.5%(37/40)阴道菌群中克隆有产H2O2的乳酸杆菌,而感染BV妇女仅有4.1%(3/72)阴道菌群中克隆有产H2O2的乳酸杆菌。作者认为,乳酸杆菌所产H2O2非特异性地起到保护阴道微环境的作用(Shopova E.Hydrogenperoxide-producing Lactobacillus species in healthy women and in women withbacterial vaginosis Akush Ginekol(Sofiia).2003;42 Suppl 1:12-5)。H2O2可以抑制某些好氧细菌和霉菌的生长。文献报道,缺乏产H2O2的乳酸杆菌,是大肠杆菌引起的阴道炎、尿道炎复发的主要因素(Juarez Tomas MS,Ocana VS,WieseB,Nader-Macias ME.Growth and lactic acid production by vaginalLactobacillus acidophilus CRL 1259,and inhibition of uropathogenicEscherichia coli.J Med Microbiol.2003 Dec;52(Pt 12):1117-24)。有人应用H2O2液冲洗阴道治疗BV感染,并与灭滴灵和氯洁霉素治疗进行比较:58名年龄在18-42岁感染BV的女性患者临床用30ml 3%H2O2液冲洗阴道,每天1次,共冲洗7天。3个月后与灭滴灵和氯洁霉素治疗进行比较,BV的主要症状得以清除,包括98%患者消除恶臭,98%阴道pH<4.5,97.7%胺试验阴性,100%阴道分泌物中未检出线索细胞并建立起含有产H2O2乳酸杆菌的正常菌群(Cardone A,Zarcone R,Borrelli A,Di Cunzolo A,Russo A,Tartaglia E.Utilisation of hydrogenperoxide in the treatment of recurrent bacterial vaginosis.Minerva Ginecol.2003 Dec;55(6):483-92)。The number of lactobacilli parasitic in the vagina of some women is not small, but inflammation still occurs, because these lactobacilli do not produce H 2 O 2 , and most of the lactobacillus parasitic in the vagina of women with good cleanliness produce H 2 O 2 . For example, Gallia investigated the vaginal flora of 40 healthy women and 72 women infected with BV in 2003, and found that 92.5% (37/40) of healthy women had Lactobacillus producing H2O2 in their vaginal flora . However, only 4.1% (3/72) of women infected with BV had Lactobacillus producing H 2 O 2 in their vaginal flora. The author believes that the H 2 O 2 produced by Lactobacillus plays a non-specific role in protecting the vaginal microenvironment (Shopova E. Hydrogenperoxide-producing Lactobacillus species in healthy women and in women with bacterial vaginosis Akush Ginekol (Sofiia). 2003; 42 Suppl 1 :12-5). H 2 O 2 can inhibit the growth of some aerobic bacteria and molds. It has been reported in the literature that the lack of Lactobacillus producing H 2 O 2 is the main factor for the recurrence of vaginitis and urethritis caused by Escherichia coli (Juarez Tomas MS, Ocana VS, WieseB, Nader-Macias ME. Growth and lactic acid production by vaginalLactobacillus acidophilus CRL 1259, and inhibition of uropathogenic Escherichia coli. J Med Microbiol. 2003 Dec;52(Pt 12):1117-24). Some people use H 2 O 2 solution to wash the vagina to treat BV infection, and compare it with metronidazole and clindamycin treatment: 58 female patients aged 18-42 years old infected with BV were clinically treated with 30ml 3% H 2 O 2 solution Wash the vagina once a day for a total of 7 days. Compared with metronidazole and clindamycin treatment after 3 months, the main symptoms of BV were cleared, including elimination of malodor in 98% of patients, 98% of vaginal pH<4.5, 97.7% negative amine test, 100% of vaginal discharge Clue cells were not detected and a normal flora containing Lactobacillus producing H 2 O 2 was established (Cardone A, Zarcone R, Borrelli A, Di Cunzolo A, Russo A, Tartaglia E. Utilization of hydrogen peroxide in the treatment of recurrent bacterial vaginosis . Minerva Ginecol. 2003 Dec;55(6):483-92).

(4)抑菌作用(4) Antibacterial effect

有些乳酸杆菌在生长过程中,可向体外分泌乳酸杆菌菌素,这些菌素对许多阴道致病微生物可产生抑制其生长的作用,这些菌素的成份和作用机理还不清楚,有研究证明乳酸杆菌菌素是一种具有抗菌作用的蛋白质成分的物质,也有人认为所谓乳酸杆菌菌素,即是乳酸杆菌的酸性代谢产物。但是无论乳酸杆菌菌素是何种成分的物质,用作阴道微生态制剂的乳酸杆菌菌株必须要有抑菌作用(Aroutcheva AA.Simoes JA,Faro S.Antimicrobial protein produced byvaginal Lactobacillus acidophilus that inbibits Gardnerella vaginalisInfect Dios Obstet gynecol 2001,9(1):33-9;Tomas MS,Claudia Otero M,OcanaV,Elena Nader-Macias M.Production of antimicrobial substances by lacticacid bacteria I:determination of hydrogen peroxide.Methods Mol Biol.2004.268:337-46)。Some lactobacilli can secrete lactobacillus bacteria in vitro during the growth process. These bacteria can inhibit the growth of many vaginal pathogenic microorganisms. The composition and mechanism of these bacteria are still unclear. Studies have shown that lactic acid Bacillus bacteriocin is a substance with antibacterial protein components, and some people think that the so-called lactobacillus bacteriocin is the acidic metabolite of Lactobacillus. However, no matter what kind of ingredients Lactobacillus is, the Lactobacillus strain used as vaginal microecological preparation must have antibacterial effect (Aroucheva AA. Simoes JA, Faro S. Antimicrobial protein produced by vaginal Lactobacillus acidophilus that inbibits Gardnerella vaginalis Infect Dios Obstet gynecol 2001, 9(1): 33-9; Tomas MS, Claudia Otero M, OcanaV, Elena Nader-Macias M. Production of antimicrobial substances by lactic acid bacteria I: determination of hydrogen peroxide. Methods Mol Biol. 2003.268 46).

(5)生长条件和稳定性(5) Growth conditions and stability

乳酸杆菌生长对营养的需求差异很大,大多数乳酸杆菌营养需求苛刻,需要高成本的营养添加剂,并且生长缓慢,不适合用于制剂生产。用作阴道微生态制剂的乳酸杆菌菌株要能够适应普通生长条件,在普通生长条件下可以大量繁殖;另外,该菌株在适宜的保存液中可以长期存活也是用作阴道微生态制剂菌株的必备条件。Lactobacillus growth has very different nutritional needs. Most Lactobacillus have strict nutritional requirements, require high-cost nutritional additives, and grow slowly, so they are not suitable for preparation production. Lactobacillus strains used as vaginal microecological preparations must be able to adapt to ordinary growth conditions, and can reproduce in large numbers under ordinary growth conditions; in addition, the strain can survive for a long time in a suitable preservation solution, which is also a must for vaginal microecological preparation strains condition.

发明内容Contents of the invention

本发明的目的是提供一株新的植物乳杆菌。The purpose of the present invention is to provide a new plant lactobacillus.

本发明所提供的植物乳杆菌是植物乳杆菌(Lactobacillus plantarum)L323,该菌株已于2005年03月14日保藏于中国普通微生物菌种保藏管理委员会普通微生物中心(简称CGMCC),保藏编号为CGMCC No.1329。The plant Lactobacillus provided by the present invention is Lactobacillus plantarum (Lactobacillus plantarum) L323, and this bacterial strain has been preserved in the General Microorganism Center (abbreviated as CGMCC) of China General Microorganism Culture Collection Management Committee (CGMCC) on March 14, 2005, and the preservation number is CGMCC No. 1329.

植物乳杆菌(Lactobacillus plantarum)L323CGMCC No.1329分离自阴道清洁度高、微环境好的人体,对妇女阴道常见的致病菌如金黄色葡萄球菌、白色念珠菌、大肠杆菌和阴道加德纳菌显示有较强的抑菌作用,产酸和产H2O2的能力均高于其它乳酸杆菌,培养96小时,培养液的pH可达3.96;该菌株表面具有厚厚的非菌毛黏附素,对阴道上皮细胞有较好的黏附作用,并且在适宜的保存液中室温放置半年,活菌数增加3×104倍。植物乳杆菌(Lactobacillus plantarum)L323CGMCC No.1329可用于制备阴道微生态制剂,用以预防和/或治疗妇女阴道感染性疾病。Lactobacillus plantarum (Lactobacillus plantarum) L323CGMCC No.1329 is isolated from human body with high vaginal cleanliness and good microenvironment. It shows a strong antibacterial effect, and the ability to produce acid and H 2 O 2 is higher than that of other lactobacilli. After 96 hours of cultivation, the pH of the culture solution can reach 3.96; the surface of the strain has thick non-pilus adhesin , has good adhesion to vaginal epithelial cells, and placed in a suitable preservation solution at room temperature for half a year, the number of viable bacteria increased by 3×10 4 times. Lactobacillus plantarum (Lactobacillus plantarum) L323CGMCC No.1329 can be used to prepare vaginal microecological preparations for preventing and/or treating women's vaginal infectious diseases.

附图说明Description of drawings

图1为植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329的革兰氏染色照片Fig. 1 is the Gram stain photo of Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329

图2A为植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329对金黄色葡萄球菌ATCC6035的抑菌作用Figure 2A is the antibacterial effect of Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329 on Staphylococcus aureus ATCC6035

图2B为植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329对白色念珠菌ATCC1023的抑菌作用Figure 2B is the antibacterial effect of Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329 on Candida albicans ATCC1023

图2C为植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329对大肠杆菌ATCC25922的抑菌作用Figure 2C is the antibacterial effect of Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329 on Escherichia coli ATCC25922

图2D为植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329对阴道加德纳菌ATCC14018的抑菌作用Figure 2D shows the antibacterial effect of Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329 on Gardnerella vaginalis ATCC14018

图3为植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329产H2O2呈蓝绿色菌落的平板照片Figure 3 is a plate photo of blue-green colonies of Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329 producing H 2 O 2

图4为植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329的电镜照片Fig. 4 is the electron micrograph of Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329

具体实施方式Detailed ways

下述实施例中的实验方法,如无特别说明,均为常规方法。The experimental methods in the following examples are conventional methods unless otherwise specified.

实施例1、植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329的分离及鉴定Embodiment 1, isolation and identification of Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329

1、植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329的分离1. Isolation of Lactobacillus plantarum L323 CGMCC No.1329

首先采集在301医院妇产科定期进行孕期检查的300余位健康中国孕妇阴道后穹窿部位分泌物,在用MRS培养基进行细菌分离的同时,进行以下几方面的试验:(1)直接涂片,根据乳酸杆菌和革兰氏阴性细菌的数量进行清洁度评价(0-2分,正常;4-6分,轻度炎症;8-10分,重度炎症),其中,阴道清洁度的评价标准参照文献(Robert P.Nugent,Marijane A.Krohn,and Sharon L.HillierReliability of diagnosing bacterial vaginosis is improved by a standardizedmethod of Gram stain interpretation Journal of Clincal Microbiology1991,29(2):297-301);(2)阴道分泌物pH测定;(3)定量测定阴道分泌物中乳酸杆菌的数量。结果得到一株分离自阴道清洁度评价为0-2分,阴道分泌物中乳酸杆菌数量大于1×108CFU/ml,pH值为3.25的阴道分泌物的乳酸杆菌,菌株号为L323。Firstly, the vaginal vaginal fornix secretions of more than 300 healthy Chinese pregnant women undergoing regular pregnancy checkups in the Obstetrics and Gynecology Department of the 301 Hospital were collected, and the following tests were carried out while using MRS medium for bacterial isolation: (1) Direct smear , according to the number of lactobacilli and gram-negative bacteria to evaluate the cleanliness (0-2 points, normal; 4-6 points, mild inflammation; 8-10 points, severe inflammation), among them, the evaluation criteria of vaginal cleanliness Reference literature (Robert P.Nugent, Marijane A.Krohn, and Sharon L.Hillier Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation Journal of Clincal Microbiology1991, 29(2):297-301); (2) vagina Secretion pH determination; (3) Quantitative determination of the number of lactobacilli in vaginal secretions. As a result, a strain of Lactobacillus isolated from vaginal secretions with a vaginal cleanliness rating of 0-2 points, the number of lactobacilli in vaginal secretions greater than 1×10 8 CFU/ml, and a pH value of 3.25 was obtained, and the strain number was L323.

2、细菌鉴定2. Bacteria identification

菌体形态观察按常规法进行革兰氏染色镜检。革兰氏染色可见L323株乳酸杆菌为革兰氏阳性粗大杆菌,大小约为1×3-8um(图1)。Bacterial morphology was observed by Gram staining microscope according to the conventional method. Gram staining showed that the L323 strain of Lactobacillus was a Gram-positive thick bacillus with a size of about 1×3-8um (Figure 1).

生化反应采用法国梅里埃生物公司API 50细菌鉴定系统,包括API 50培养基、试验条、McFarland标准点、矿物油、培养盒和API Plus软件等。API 50细菌鉴定系统鉴定结果表明L323株乳酸杆菌为植物乳杆菌(Lactobacillusplantarum),其生化反应结果如表1所示。The biochemical reaction adopts the API 50 bacterial identification system of French Mérieux Biotechnology Company, including API 50 medium, test strips, McFarland standard points, mineral oil, culture box and API Plus software. The identification results of the API 50 bacterial identification system showed that L323 strain Lactobacillus was Lactobacillus plantarum (Lactobacillus plantarum), and its biochemical reaction results are shown in Table 1.

表1  植物乳杆菌(Lactobacillus plantarum)L323的生化反应Table 1 Biochemical reactions of Lactobacillus plantarum L323

  七叶灵ESCAesculin ESC   ++   木糖醇XLTXylitol XLT   --   甘油GLYGlycerin GLY   --   龙胆二糖GENGentiobiose GEN   ++   赤癣醇ERYErythrasol ERY   --   D-松二糖TURD-turanose TUR   ++   D-阿拉伯糖DARAD-Arabinose DARA   --   D-来苏糖LYXD-lyxose LYX   --   L-阿拉伯糖LARAL-Arabinose LARA   ++   D-塔格糖TAGD-tagatose TAG   --   核糖RIBRibose RIB   ++   D-岩糖DFUCD-rock sugar DFUC   --   D-木糖DXYLD-xylose DXYL   --   L-岩糖LFUCL-rock sugar LFUC   --   L-木糖LXYLL-xylose LXYL   --   D-阿拉伯糖醇DARLD-Arabitol DARL   ++   阿东糖ADOAdon sugar ADO   --   L-阿拉伯糖醇LARLL-Arabitol LARL   --   β-甲基-D-木糖甙MDXβ-Methyl-D-xyloside MDX   --   葡萄糖酸盐GNTGluconate GNT   ++   半乳糖GALGalactose GAL   ++   2-酮基-葡萄糖酸盐2KG2-keto-gluconate 2KG   --   葡萄糖GLUGlucose GLU   ++   5-酮基-葡萄糖酸盐5KG5-keto-gluconate 5KG   ++   果糖FRUFructose FRU   ++   肝糖GLYGGlycogen GLYG   --   甘露糖MNEMannose MNE   ++   淀粉AMDStarch AMD   --   山梨糖SBESorbose SBE   --   棉子糖RAFRaffinose RAF   ++   鼠李糖RHARhamnose RHA   --   松叁糖MLZSongsan sugar MLZ   ++   卫茅醇DULWermaol DUL   --   菊糖INUInulin INU   --   肌醇INOInositol INO   --   海藻糖TRETrehalose TRE   ++   甘露醇MANMannitol MAN   ++   蔗糖SACSucrose SAC   ++   山梨醇SORSorbitol SOR   ++   蜜二糖MELMelibiose MEL   ++   α-甲基-D-甘露甙MDMα-Methyl-D-mannoside MDM   ++   乳糖LACLactose LAC   ++

  七叶灵ESCAesculin ESC   ++   木糖醇XLTXylitol XLT   --   α-甲基-D-葡萄糖甙MDGα-Methyl-D-glucoside MDG   --   麦芽糖MALMaltose MAL   ++   N-乙酰-葡萄胺NAGN-acetyl-glucosamine NAG   ++   纤维二糖CELCellobiose CEL   ++   苦杏仁甙AMYLaetrile AMY   ++   柳醇SALWillow Alcohol SAL   ++   熊果甙ARBArbutin ARB   ++

注:“+”为反应阳性,“-”为反应阴性。Note: "+" means positive reaction, "-" means negative reaction.

实施例2、植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329的特性Embodiment 2, the characteristic of plant lactobacillus (Lactobacillus plantarum) L323 CGMCC No.1329

材料Material

菌株金黄色葡萄球菌ATCC6035、白色念珠菌ATCC1023、大肠杆菌ATCC25922、阴道加德纳菌ATCC14018Strains Staphylococcus aureus ATCC6035, Candida albicans ATCC1023, Escherichia coli ATCC25922, Gardnerella vaginalis ATCC14018

试剂Reagent

MRS培养基、LM肉汤培养基,购自法国梅里埃生物公司;MRS medium and LM broth medium were purchased from Mérieux Biological Company of France;

胰蛋白胨、酵母抽提物、琼脂粉,购自Oxide;Tryptone, yeast extract, and agar powder were purchased from Oxide;

四甲基联苯胺(TMB)、二甲基甲酰胺、辣根过氧化物酶(HRP),购自Sigma公司。Tetramethylbenzidine (TMB), dimethylformamide, and horseradish peroxidase (HRP) were purchased from Sigma.

1、抑菌试验1. Antibacterial test

将植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329菌株接种于MRS培养基,37℃、5%CO2培养24小时,用无菌生理盐水洗下菌苔,比浊并稀释成1×108CFU/ml浓度菌液,将直径为5mm的圆形灭菌滤纸片浸满菌液后备用。Inoculate Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329 strain in MRS medium, culture at 37°C, 5% CO 2 for 24 hours, wash the bacterial lawn with sterile saline, turbidity and dilute to 1×10 8 CFU/ml concentration of bacterial liquid, soak a circular sterile filter paper piece with a diameter of 5mm in the bacterial liquid and set aside.

将金黄色葡萄球菌ATCC6035、白色念珠菌ATCC1023、大肠杆菌ATCC25922分别接种于普通营养琼脂培养基(牛肉膏3.0克/L,蛋白胨10.0克/L,NaCl 5.0克/L,琼脂15克/L,pH 7.0)上,37℃培养24小时,阴道加德纳菌ATCC14018接种于GC血琼脂,37℃5%CO2培养24小时,分别用无菌生理盐水洗下菌体,比浊并稀释成1×108CFU/ml浓度菌液,各取0.1ml涂布普通营养琼脂平板,将上述浸有植物乳杆菌(Lactobacillus plantarum)L323CGMCC No.1329的圆形滤纸片分别放在涂布有上述细菌的平板中间位置,贴紧,做好标记,将涂有金黄色葡萄球菌ATCC6035、白色念珠菌ATCC1023、大肠杆菌ATCC25922的平板分别放入普通培养箱,将涂有阴道加德纳菌ATCC14018的平板分别放入5%CO2孵箱,37℃培养48小时,测量记录抑菌圈直径并照相。Staphylococcus aureus ATCC6035, Candida albicans ATCC1023 and Escherichia coli ATCC25922 were inoculated on common nutrient agar medium (beef extract 3.0 g/L, peptone 10.0 g/L, NaCl 5.0 g/L, agar 15 g/L, pH 7.0), cultured at 37°C for 24 hours, Gardnerella vaginalis ATCC14018 was inoculated on GC blood agar, cultured at 37°C with 5% CO 2 for 24 hours, washed with sterile saline, turbidimetric and diluted to 1× 10 8 CFU/ml concentration of bacteria solution, each take 0.1ml coated with common nutrient agar plate, the above-mentioned circular filter paper soaked with Lactobacillus plantarum (Lactobacillus plantarum) L323CGMCC No.1329 were placed on the flat plate coated with the above bacteria Put the plates coated with Staphylococcus aureus ATCC6035, Candida albicans ATCC1023, and E. Incubate at 37°C for 48 hours in a 5% CO 2 incubator, measure and record the diameter of the inhibition zone and take pictures.

抑菌试验的结果如表2和图2A-图2D所示,表明植物乳杆菌(Lactobacillusplantarum)L323 CGMCC No.132对金黄色葡萄球菌、白色念珠菌、大肠杆菌和阴道加德纳菌(金黄色葡萄球菌、白色念珠菌、大肠杆菌和阴道加德纳菌均是引起阴道炎常见致病菌)具有抑菌作用。说明植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.132对妇女阴道常见的致病菌有较好的抑菌效果。The result of bacteriostasis test is shown in table 2 and Fig. 2A-Fig. 2D, shows that plant lactobacillus (Lactobacillus plantarum) L323 CGMCC No.132 is to Staphylococcus aureus, Candida albicans, escherichia coli and vaginal Gardnerella (golden yellow Staphylococcus, Candida albicans, Escherichia coli and Gardnerella vaginalis are common pathogenic bacteria that cause vaginitis) have antibacterial effect. It shows that Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.132 has a good antibacterial effect on common pathogenic bacteria in women's vagina.

表2  L323株乳酸杆菌对常见致病菌的抑菌效果Table 2 Antibacterial effect of L323 strain Lactobacillus on common pathogenic bacteria

Figure G2005100800722D00091
Figure G2005100800722D00091

2、产酸酸度和成分分析试验2. Acidity and component analysis test of acid production

将植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329接种于MRS培养基,37℃5%CO2培养24小时后,用生理盐水洗下菌苔,制成1×108CFU/ml菌悬液,取0.1ml菌悬液接种于5ml LM肉汤培养基中,37℃5%CO2分别培养24小时、48小时、72小时、96小时,用pH酸度仪测定不同时间培养菌液的pH值。Inoculate Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329 in MRS medium, culture at 37°C 5% CO 2 for 24 hours, wash the bacterial lawn with physiological saline, and make 1×10 8 CFU/ml bacterial suspension , take 0.1ml of bacterial suspension and inoculate it in 5ml of LM broth medium, culture at 37°C with 5% CO2 for 24 hours, 48 hours, 72 hours, and 96 hours respectively, and use a pH meter to measure the pH value of the cultured bacterial solution at different times .

植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329的不同培养时间培养液的pH值的变化情况如表3所示。The variation of the pH value of the culture solution of Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329 at different culture times is shown in Table 3.

表3.植物乳杆菌L323不同时间产酸试验结果Table 3. Test results of acid production of Lactobacillus plantarum L323 at different times

Figure G2005100800722D00101
Figure G2005100800722D00101

取上述培养24小时的乳酸杆菌LM肉汤培养基10ml,8000rpm离心15分钟,弃菌体沉淀,收集上清,对细菌代谢产物中的短碳有机酸:乙酸、丙酸、丁酸、戊酸进行气相色谱分析。结果如表4所示,表明植物乳杆菌(Lactobacillusplantarum)L323 CGMCC No.1329产生的短碳有机酸主要为乙酸,培养24小时生产乙酸可达1160ug/ml。Take 10ml of the Lactobacillus LM broth medium cultured for 24 hours, centrifuge at 8000rpm for 15 minutes, discard the bacterial sediment, collect the supernatant, and analyze the short-carbon organic acids in the bacterial metabolites: acetic acid, propionic acid, butyric acid, valeric acid Perform gas chromatographic analysis. The results are shown in Table 4, indicating that the short-carbon organic acid produced by Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329 is mainly acetic acid, which can reach 1160ug/ml in 24 hours of cultivation.

表4.植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329产酸的成分和产量分析Table 4. Composition and yield analysis of acid produced by Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329

  有机酸成分Organic acid components   产量(ug/ml)Yield (ug/ml)   乙酸Acetic acid   11601160   丙酸propionic acid   <50<50   丁酸butyric acid   <50<50   戊酸Valeric acid   <20<20

3、产过氧化氢(H2O2)试验3. Hydrogen peroxide (H 2 O 2 ) test

称取四甲基联苯胺(TMB)12.5mg溶于1ml二甲基甲酰胺中,与50ml MRS培养基混匀,121℃15分钟灭菌后铺平板,得到TMB-MRS培养基平板,4℃避光放置备用。Weigh 12.5mg of tetramethylbenzidine (TMB) and dissolve it in 1ml of dimethylformamide, mix it with 50ml of MRS medium, sterilize at 121°C for 15 minutes, and plate it to obtain a TMB-MRS medium plate. Store away from light for later use.

按0.01mg/ml浓度配制辣根过氧化物酶(HRP)溶液,0.45μm滤膜过滤除菌,菌株接种前取0.1ml均匀涂布TMB-MRS培养基平板,晾干,4℃避光放置。Prepare a horseradish peroxidase (HRP) solution at a concentration of 0.01 mg/ml, and filter it through a 0.45 μm membrane to sterilize it. Before inoculating the strain, take 0.1 ml and evenly coat the TMB-MRS medium plate, dry it, and place it in the dark at 4°C .

将植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329接种于上述涂布有HRP的TMB-MRS培养基,37℃5%CO2孵箱避光培养24小时,取出培养板,暴露光线3分钟后,观察培养板上菌落颜色变化并记录结果。结果判读:在有H2O2存在的情况下,HRP会氧化TMB形成蓝绿色氧化物。因此,如果乳酸菌产H2O2,生长于含有TMB、并涂布有HRP的培养基上的菌落将会变为蓝绿色,而不产生H2O2的乳酸菌株的菌落为灰白色。结果如图3所示,植物乳杆菌(Lactobacillusplantarum)L323 CGMCC No.1329产H2O2呈蓝绿色菌落。乳酸杆菌产生H2O2可使阴道微环境缺氧,从而抑制好氧致病菌生长。有试验表明,由大肠杆菌引起的复发性阴道炎和尿道炎患者阴道和尿道内缺乏产H2O2的乳酸杆菌(Wilks M,Wiggins R,Whiley A,Hennessy E,Warwick S,Porter H,Corfield A,Millar M.Identification and H(2)O(2)production of vaginal lactobacilli frompregnant women at high risk of preterm birth and relation with outcome.J Clin Microbiol.2004 Feb;42(2):713-717)。Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329 was inoculated on the above-mentioned TMB-MRS medium coated with HRP, and cultured in a 5% CO2 incubator at 37°C in the dark for 24 hours, and the culture plate was taken out and exposed to light for 3 minutes. , observe the color change of the colonies on the culture plate and record the results. Interpretation of the results: In the presence of H 2 O 2 , HRP will oxidize TMB to form a blue-green oxide. Therefore, if the lactic acid bacteria produce H 2 O 2 , the colonies grown on the medium containing TMB and coated with HRP will turn blue-green, while the colonies of the non-H 2 O 2 producing lactic acid bacteria strains will be off-white. The results are shown in FIG. 3 , the colonies of Lactobacillus plantarum L323 CGMCC No.1329 producing H 2 O 2 were blue-green. The production of H 2 O 2 by Lactobacillus can make the vaginal microenvironment hypoxic, thereby inhibiting the growth of aerobic pathogenic bacteria. Trials have shown a lack of H2O2 - producing lactobacilli in the vagina and urethra of patients with recurrent vaginitis and urethritis caused by Escherichia coli (Wilks M, Wiggins R, Whiley A, Hennessy E, Warwick S, Porter H, Corfield A, Millar M. Identification and H(2)O(2)production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome. J Clin Microbiol. 2004 Feb; 42(2): 713-717).

4、菌株超微结构的电镜观察4. Electron microscope observation of strain ultrastructure

植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329接种MRS培养基37℃5%CO2培养24h,用无菌棉拭子拭取菌苔接种于5ml LM肉汤培养基,37℃5%CO2培养24小时,5000rpm/min离心10分钟,弃上清,正常小鼠眼球取血后立即分离血清,取新鲜分离的小鼠血清1滴滴入菌体沉淀中,室温放置10分钟使菌块固定,加入戊二醛固定液1ml,放置4℃用于电镜标本的制备。电镜观察结果如图4所示,植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329菌体表面具有厚厚的毛发样突出物,即非菌毛黏附素,该物质是细菌黏附上皮细胞的基础。Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329 was inoculated with MRS medium at 37°C with 5% CO 2 and cultured for 24 hours, and the bacterial lawn was swabbed with a sterile cotton swab and inoculated into 5ml LM broth medium at 37°C with 5% CO 2 Cultivate for 24 hours, centrifuge at 5000rpm/min for 10 minutes, discard the supernatant, and separate the serum immediately after taking blood from the eyeballs of normal mice. Take 1 drop of freshly separated mouse serum and drop it into the bacterial pellet, and place it at room temperature for 10 minutes to fix the bacterial block , add 1ml of glutaraldehyde fixative, and place at 4°C for preparation of electron microscope specimens. Electron microscope observation results are shown in Figure 4, Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCC No.1329 has thick hair-like protrusions on the surface of the bacteria, that is, non-pilus adhesin, which is the basis for bacteria to adhere to epithelial cells.

5、菌株保存的稳定性试验5. Stability test of strain preservation

观察乳酸杆菌在不同保存液中细菌的存活情况。Observe the survival of Lactobacillus in different preservation solutions.

保存液的配制:Preservation solution preparation:

保存液1:MRS培养基+5%(质量百分含量)脱脂牛奶Preservation solution 1: MRS medium + 5% (mass percentage) skimmed milk

保存液2:MRS培养基+5%(质量百分含量)脱脂牛奶+海藻糖3.78gPreservation solution 2: MRS medium + 5% (mass percentage content) skim milk + trehalose 3.78g

保存液3:MRS培养基Preservation solution 3: MRS medium

将24小时培养的植物乳杆菌(Lactobacillus plantarum)L323 CGMCC No.1329以4800rpm/min离心5分钟,以不同保存液悬浮沉淀菌体,菌体计数为2.2×105CFU/ml,分别分装保存管0.5ml/支,分别放置不同温度(37℃,室温)环境中避光保存,每月各取保存管1支,吸出菌液0.1ml,用1ml LB肉汤稀释成不同浓度,涂布MRS培养基平板,37℃5%CO2培养24小时后计数,观察并记录不同保存液保存效果,即细菌存活情况。植物乳杆菌(Lactobacillus plantarum)L323 CGMCCNo.1329的存活情况如表5所示。Centrifuge the Lactobacillus plantarum L323 CGMCC No.1329 cultivated for 24 hours at 4800rpm/min for 5 minutes, suspend and precipitate the bacteria in different preservation solutions, the bacterial count is 2.2×10 5 CFU/ml, and store them separately Tube 0.5ml/tube, put them in different temperature (37℃, room temperature) environments and store them away from light. Take 1 tube each month, suck out 0.1ml of bacterial solution, dilute it with 1ml LB broth to different concentrations, and apply MRS The medium plates were cultured at 37° C. in 5% CO 2 for 24 hours, counted, and the preservation effects of different preservation solutions, that is, the survival of bacteria, were observed and recorded. The survival of Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCCNo.1329 is shown in Table 5.

表5.不同保存液中植物乳杆菌(Lactobacillus plantarum)L323 CGMCCNo.1329的存活数(CFU/ml)Table 5. Survival number (CFU/ml) of Lactobacillus plantarum (Lactobacillus plantarum) L323 CGMCCNo.1329 in different preservation solutions

Claims (2)

1. plant lactobacillus (Lactobacillus plantarum) L323 CGMCC No.1329.
2. plant lactobacillus (Lactobacillus plantarum) L323 CGMCC No.1329 prevents and/or treats application in the woman vagina infectious disease medicament in preparation.
CN200510080072A 2005-06-28 2005-06-28 Plant lactobacillus strain and its application Expired - Fee Related CN1888051B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200510080072A CN1888051B (en) 2005-06-28 2005-06-28 Plant lactobacillus strain and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200510080072A CN1888051B (en) 2005-06-28 2005-06-28 Plant lactobacillus strain and its application

Publications (2)

Publication Number Publication Date
CN1888051A CN1888051A (en) 2007-01-03
CN1888051B true CN1888051B (en) 2010-05-05

Family

ID=37577336

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200510080072A Expired - Fee Related CN1888051B (en) 2005-06-28 2005-06-28 Plant lactobacillus strain and its application

Country Status (1)

Country Link
CN (1) CN1888051B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101974449B (en) * 2010-09-13 2012-06-06 郑州大学 Lactobacillus plantarum and application thereof
CN101974467B (en) * 2010-10-26 2012-10-24 郑州大学 Lactobacillus plantarum and application thereof
CN101974468B (en) * 2010-10-26 2012-04-18 郑州大学 Lactobacillus plantarum and application thereof
FR2992861B1 (en) * 2012-07-09 2014-10-17 Probionov USE OF THIOSULFATE FOR POTENTIATING THE ANTI-PATHOGENIC EFFECT OF LACTOBACILLES
CN103911306B (en) * 2013-01-05 2016-08-24 欣力菲生物医药技术(天津)有限公司 Lactobacillus gasseri bacterial strain and application thereof
CN103911309B (en) * 2013-01-05 2016-08-24 欣力菲生物医药技术(天津)有限公司 Lactobacillus gasseri bacterial strain and application thereof
CN106166163A (en) * 2016-09-05 2016-11-30 北京蓝色美城科技有限公司 A kind of feminine wash of the fermentation supernatant containing lactic acid bacteria
CN106167786A (en) * 2016-09-05 2016-11-30 北京蓝色美城科技有限公司 One strains of lactic acid bacteria and application thereof
CN107299065B (en) * 2017-06-20 2020-02-14 广东强基药业有限公司 Lactobacillus plantarum and application thereof in preparation of vagina bacteriostatic drugs
CN108295096B (en) * 2017-12-21 2020-12-25 天津科睿恒生物科技有限公司 Application of bacterial strain in preparation for preventing and treating mycotic and bacterial vaginosis
KR101930438B1 (en) * 2018-10-12 2018-12-18 (주) 에이투젠 Novel Lactobacillus plantarum strain ATG-K2, ATG-K6 or ATG-K8, and composition comprising thereof for preventing or treating vaginosis
CN109439592A (en) * 2018-12-06 2019-03-08 青岛东海药业有限公司 Lactobacillus plantarum preparation and its application
CN109504630B (en) * 2018-12-17 2022-03-11 吉林中粮生化有限公司 Lactobacillus plantarum strain produced by recombinant D-lactic acid and method for producing D-lactic acid by using strain
CN109628354A (en) * 2019-01-30 2019-04-16 江南大学 The lactobacillus plantarum of one plant height bacteriostatic activity and application
CN111000873A (en) * 2019-09-03 2020-04-14 江苏中天药业有限公司 Lactobacillus vaginal effervescent capsule and preparation method thereof
CN112798370A (en) * 2020-12-24 2021-05-14 桂林优利特医疗电子有限公司 Quality control material for detecting visible components of vaginal secretion and preparation method thereof
CN114717150B (en) * 2022-04-20 2023-01-17 河北农业大学 Lactobacillus plantarum CRS33 and application thereof
CN114869917B (en) * 2022-07-07 2022-10-28 微康益生菌(苏州)股份有限公司 Application of lactobacillus plantarum N13 in preparation of medicine for preventing and treating vaginitis or inhibiting pathogenic bacteria
CN116103189B (en) * 2022-09-15 2025-07-18 广东君薇生物科技有限公司 Lactobacillus plantarum and application thereof
CN116004457B (en) * 2022-12-28 2024-05-07 内蒙古双奇药业股份有限公司 Humanized lactobacillus plantarum and application thereof
CN117778271A (en) * 2024-01-18 2024-03-29 浙江大学 A strain of Lactobacillus plantarum ZJUIDS-20 that inhibits Gardnerella vaginalis and its application

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1185111A (en) * 1995-03-23 1998-06-17 普罗比公司 Eipthelial adhesive lactobacilli

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1185111A (en) * 1995-03-23 1998-06-17 普罗比公司 Eipthelial adhesive lactobacilli

Also Published As

Publication number Publication date
CN1888051A (en) 2007-01-03

Similar Documents

Publication Publication Date Title
CN1888051B (en) Plant lactobacillus strain and its application
EP3040413B1 (en) Lactobacillus crispatus and application thereof
CN107299065B (en) Lactobacillus plantarum and application thereof in preparation of vagina bacteriostatic drugs
CN108004187B (en) Lactobacillus gasseri and application thereof in preparing vagina bacteriostatic drug
CN104560820B (en) VREF KQ2.6 and application
CN107794236B (en) Lactobacillus crispatus and application thereof
CN107267415B (en) Lactobacillus reuteri and application thereof in preparing vagina bacteriostatic drug
WO2022100631A1 (en) Lactobacillus crispatus for preventing and/or treating genital tract flora disorder related diseases
CN114250186B (en) Lactobacillus gasseri strain for relieving bacterial vaginitis and application thereof
CN108004188B (en) Lactobacillus rhamnosus and application thereof in preparing vagina bacteriostatic medicine
CN110540945B (en) Lactobacillus jensenii and application thereof in preparing vaginal antibacterial drugs
WO2022100632A1 (en) Lacticaseibacillus rhamnosus for preventing and/or treating diseases caused by reproductive tract flora disorder and/or bone loss
CN111518714A (en) A strain of Lactobacillus crispatus capable of preventing and/or treating Candida vaginitis
CN110157645A (en) A kind of Lactobacillus salivarius Y4 and its application
Zhang et al. Inhibitory effect of Lactobacillus gasseri CCFM1201 on Gardnerella vaginalis in mice with bacterial vaginosis
CN115725456A (en) A kind of Lactobacillus salivarius and application thereof
WO2025152761A1 (en) Lactobacillus crispatus and molecular marker and use thereof
CN112538441B (en) Lactobacillus reuteri CCFM1144 for relieving diarrhea caused by ETEC and application thereof
Tareq et al. An application of bacteriocin-producing vaginal Lactobacillus Crispatus IS30 in a gel formula against some vaginal pathogens
CN116790431A (en) Bifidobacterium animalis subspecies lactis and microbial agent capable of relieving constipation and diarrhea and application thereof
CN104293718B (en) Lactobacillus jensenii and application thereof
KR20100079078A (en) Pharmaceutical compositions including lactobacillus fermentum no. 1969 for treatment of vaginal infections
CN119040176A (en) A strain of Lactobacillus crispatus and its application
CN117327604A (en) Live bacterial preparation containing lactobacillus rhamnosus strain and application thereof
CN120758425B (en) A probiotic composition containing Lactobacillus gasseri LN32 and Lactobacillus curvature LN70 and its application in reducing the risk of vaginal infections.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100505

Termination date: 20110628